Ticker
SNDXCompany Name
SYNDAX PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Current Assets | Inventory | Current Liabilities | Quick Ratio |
---|---|---|---|---|
6/30/2025 | $ 531.68M | $ 17.7M | $ 112.99M | 4.55 |
3/31/2025 | $ 548.75M | $ 4.66M | $ 94.55M | 5.75 |
12/31/2024 | $ 603.06M | $ 366K | $ 103.55M | 5.82 |
9/30/2024 | $ 414.81M | $ 0 | $ 59.38M | 6.99 |
6/30/2024 | $ 446.06M | $ 0 | $ 42.47M | 10.5 |
3/31/2024 | $ 453.9M | $ 0 | $ 50.8M | 8.93 |
12/31/2023 | $ 580.88M | $ 0 | $ 58.1M | 10 |
9/30/2023 | $ 380.97M | $ 0 | $ 39.17M | 9.73 |
6/30/2023 | $ 409.08M | $ 0 | $ 30.17M | 13.56 |
3/31/2023 | $ 441.51M | $ 0 | $ 23.72M | 18.61 |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(AssetsC - Inventory) / LiabilitesC
(=) Quick Ratio
Quick Ratio for SYNDAX PHARMACEUTICALS INC is calculated as follows: (AssetsC [ $ 177.43M ] - Inventory [ $ 0 ]) / LiabilitesC [ $ 15.16M ]
(=) Quick Ratio [ 11.71 ]
Minimum
Jun 30, 2025
Maximum
Dec 31, 2021
Average
Median
filtered constituents | 3.12K |
---|---|
min | -0.73 |
max | 5.45 |
average | 1.55 |
median | 1.23 |
std | 1.17 |